A Post Marketing Study of the Safety, Tolerability, and Pharmacokinetics of TPOXX In Adult Subjects Weighing More Than 120 KG
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Tecovirimat (Primary)
- Indications Smallpox
- Focus Pharmacokinetics
- Sponsors SIGA Technologies
Most Recent Events
- 21 May 2020 New trial record